193 related articles for article (PubMed ID: 22191507)
41. Single particle reconstruction of the human apo-transferrin-transferrin receptor complex.
Cheng Y; Zak O; Aisen P; Harrison SC; Walz T
J Struct Biol; 2005 Dec; 152(3):204-10. PubMed ID: 16343946
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms by Which Salt Concentration Moderates the Dynamics of Human Serum Transferrin.
Abdizadeh H; Atilgan AR; Atilgan C
J Phys Chem B; 2017 May; 121(18):4778-4789. PubMed ID: 28443330
[TBL] [Abstract][Full Text] [Related]
43. Mutagenesis of the aspartic acid ligands in human serum transferrin: lobe-lobe interaction and conformation as revealed by antibody, receptor-binding and iron-release studies.
Mason A; He QY; Tam B; MacGillivray RA; Woodworth R
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):35-40. PubMed ID: 9461487
[TBL] [Abstract][Full Text] [Related]
44. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor.
Bennett MJ; Lebrón JA; Bjorkman PJ
Nature; 2000 Jan; 403(6765):46-53. PubMed ID: 10638746
[TBL] [Abstract][Full Text] [Related]
45. Noncanonical interactions between serum transferrin and transferrin receptor evaluated with electrospray ionization mass spectrometry.
Leverence R; Mason AB; Kaltashov IA
Proc Natl Acad Sci U S A; 2010 May; 107(18):8123-8. PubMed ID: 20404192
[TBL] [Abstract][Full Text] [Related]
46. Molecular modeling of human serum transferrin for rationalizing the changes in its physicochemical properties induced by iron binding. Implication of the mechanism of binding to its receptor.
Yajima H; Sakajiri T; Kikuchi T; Morita M; Ishii T
J Protein Chem; 2000 Apr; 19(3):215-23. PubMed ID: 10981814
[TBL] [Abstract][Full Text] [Related]
47. Differential effect of a his tag at the N- and C-termini: functional studies with recombinant human serum transferrin.
Mason AB; He QY; Halbrooks PJ; Everse SJ; Gumerov DR; Kaltashov IA; Smith VC; Hewitt J; MacGillivray RT
Biochemistry; 2002 Jul; 41(30):9448-54. PubMed ID: 12135367
[TBL] [Abstract][Full Text] [Related]
48. The anion requirement for iron release from transferrin is preserved in the receptor-transferrin complex.
Egan TJ; Zak O; Aisen P
Biochemistry; 1993 Aug; 32(32):8162-7. PubMed ID: 8347616
[TBL] [Abstract][Full Text] [Related]
49. The chloride effect is related to anion binding in determining the rate of iron release from the human transferrin N-lobe.
He QY; Mason AB; Nguyen V; MacGillivray RT; Woodworth RC
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):909-15. PubMed ID: 10970808
[TBL] [Abstract][Full Text] [Related]
50. Properties of a homogeneous C-lobe prepared by introduction of a TEV cleavage site between the lobes of human transferrin.
Steere AN; Roberts SE; Byrne SL; Dennis Chasteen N; Bobst CE; Kaltashov IA; Smith VC; MacGillivray RT; Mason AB
Protein Expr Purif; 2010 Jul; 72(1):32-41. PubMed ID: 20064616
[TBL] [Abstract][Full Text] [Related]
51. Detailed molecular dynamics simulations of human transferrin provide insights into iron release dynamics at serum and endosomal pH.
Abdizadeh H; Atilgan AR; Atilgan C
J Biol Inorg Chem; 2015 Jun; 20(4):705-18. PubMed ID: 25792380
[TBL] [Abstract][Full Text] [Related]
52. [13C]Methionine NMR and metal-binding studies of recombinant human transferrin N-lobe and five methionine mutants: conformational changes and increased sensitivity to chloride.
He QY; Mason AB; Tam BM; MacGillivray RT; Woodworth RC
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):881-7. PubMed ID: 10585877
[TBL] [Abstract][Full Text] [Related]
53. Mutations at nonliganding residues Tyr-85 and Glu-83 in the N-lobe of human serum transferrin. Functional second shell effects.
He QY; Mason AB; Woodworth RC; Tam BM; MacGillivray RT; Grady JK; Chasteen ND
J Biol Chem; 1998 Jul; 273(27):17018-24. PubMed ID: 9642266
[TBL] [Abstract][Full Text] [Related]
54. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ
Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990
[TBL] [Abstract][Full Text] [Related]
55. Computational approaches for deciphering the equilibrium and kinetic properties of iron transport proteins.
Abdizadeh H; Atilgan AR; Atilgan C; Dedeoglu B
Metallomics; 2017 Nov; 9(11):1513-1533. PubMed ID: 28967944
[TBL] [Abstract][Full Text] [Related]
56. Human serum transferrin: is there a link among autism, high oxalate levels, and iron deficiency anemia?
Luck AN; Bobst CE; Kaltashov IA; Mason AB
Biochemistry; 2013 Nov; 52(46):8333-41. PubMed ID: 24152109
[TBL] [Abstract][Full Text] [Related]
57. Biochemical and structural characterization of recombinant human serum transferrin from rice (Oryza sativa L.).
Steere AN; Bobst CE; Zhang D; Pettit SC; Kaltashov IA; Huang N; Mason AB
J Inorg Biochem; 2012 Nov; 116():37-44. PubMed ID: 23010327
[TBL] [Abstract][Full Text] [Related]
58. Point Mutations in TbpA Abrogate Human Transferrin Binding in Neisseria gonorrhoeae.
Greenawalt AN; Stoudenmire J; Lundquist K; Noinaj N; Gumbart JC; Cornelissen CN
Infect Immun; 2022 Nov; 90(11):e0041422. PubMed ID: 36321833
[TBL] [Abstract][Full Text] [Related]
59. The oxalate effect on release of iron from human serum transferrin explained.
Halbrooks PJ; Mason AB; Adams TE; Briggs SK; Everse SJ
J Mol Biol; 2004 May; 339(1):217-26. PubMed ID: 15123433
[TBL] [Abstract][Full Text] [Related]
60. Cobalt and the iron acquisition pathway: competition towards interaction with receptor 1.
Chikh Z; Hémadi M; Miquel G; Ha-Duong NT; El Hage Chahine JM
J Mol Biol; 2008 Jul; 380(5):900-16. PubMed ID: 18579154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
